Antibiotic therapy for foot infections in diabetics.
Hu
X H
XH
Markson
L E
LE
Abbott
T A
TA
Dasbach
E J
EJ
Berger
M L
ML
D000667:Ampicillin / Q000191:economics / Q000627:therapeutic use; D015377:Cilastatin / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017719:Diabetic Foot / Q000188:drug therapy*; D004359:Drug Therapy, Combination / Q000191:economics / Q000627:therapeutic use*; D005534:Foot Diseases / Q000188:drug therapy*; D006801:Humans; D015378:Imipenem / Q000191:economics / Q000627:therapeutic use; D013407:Sulbactam / Q000191:economics / Q000627:therapeutic use
D015377:Cilastatin; D015378:Imipenem; D000667:Ampicillin; D013407:Sulbactam